1病历资料患者男,74岁,因'头晕3 d'来我院就诊。患者2015-04-21在家活动时无诱因出现头晕症状,伴有视物旋转,视物模糊、四肢乏力、行走不稳等症状,就诊于我院急诊,头颅CT排除'脑出血、急性脑梗死'后,以'脑血管病后...1病历资料患者男,74岁,因'头晕3 d'来我院就诊。患者2015-04-21在家活动时无诱因出现头晕症状,伴有视物旋转,视物模糊、四肢乏力、行走不稳等症状,就诊于我院急诊,头颅CT排除'脑出血、急性脑梗死'后,以'脑血管病后遗症、高血压病'收入我科。既往有高血压病史45年,血压最高达220/100 mm Hg(1 mm Hg=0.133 k Pa),曾因血压控制不佳于1997年、展开更多
Amlodipine/valsartan(Aml/Val)single-pill combination(SPC)therapy has been widely used and studied in clinical practice in recent years.This article reviews the Chinese and English literature on the clinical use of Aml...Amlodipine/valsartan(Aml/Val)single-pill combination(SPC)therapy has been widely used and studied in clinical practice in recent years.This article reviews the Chinese and English literature on the clinical use of Aml/Val SPC therapy in Chinese hypertensive patients.According to five studies concerning the efficacy and safety of this treatment,Aml/Val SPC therapy was more efficacious than monotherapy with valsartan,amlodipine,or the nifedipine gastrointestinal therapeutic system.This treatment showed greater blood pressure-lowering effects,a higher blood pressure control rate,and a higher response rate.Aml/Val SPC treatment was well tolerated,with adverse event rates similar to those of monotherapy with valsartan or amlodipine and significantly rarer adverse events compared with the nifedipine gastrointestinal therapeutic system.Aml/Val SPC is a highly efficacious and well-tolerated antihypertensive treatment in Chinese hypertensive patients.展开更多
文摘1病历资料患者男,74岁,因'头晕3 d'来我院就诊。患者2015-04-21在家活动时无诱因出现头晕症状,伴有视物旋转,视物模糊、四肢乏力、行走不稳等症状,就诊于我院急诊,头颅CT排除'脑出血、急性脑梗死'后,以'脑血管病后遗症、高血压病'收入我科。既往有高血压病史45年,血压最高达220/100 mm Hg(1 mm Hg=0.133 k Pa),曾因血压控制不佳于1997年、
文摘Amlodipine/valsartan(Aml/Val)single-pill combination(SPC)therapy has been widely used and studied in clinical practice in recent years.This article reviews the Chinese and English literature on the clinical use of Aml/Val SPC therapy in Chinese hypertensive patients.According to five studies concerning the efficacy and safety of this treatment,Aml/Val SPC therapy was more efficacious than monotherapy with valsartan,amlodipine,or the nifedipine gastrointestinal therapeutic system.This treatment showed greater blood pressure-lowering effects,a higher blood pressure control rate,and a higher response rate.Aml/Val SPC treatment was well tolerated,with adverse event rates similar to those of monotherapy with valsartan or amlodipine and significantly rarer adverse events compared with the nifedipine gastrointestinal therapeutic system.Aml/Val SPC is a highly efficacious and well-tolerated antihypertensive treatment in Chinese hypertensive patients.
